Please login to the form below

Not currently logged in
Email:
Password:

CEPI

This page shows the latest CEPI news and features for those working in and with pharma, biotech and healthcare.

China’s Sinopharm given WHO emergency use listing for COVID-19 vaccine

China’s Sinopharm given WHO emergency use listing for COVID-19 vaccine

COVAX is the vaccine pillar of the WHO’s ACT Accelerator – a collaborative initiative co-led by Gavi, the WHO and the Coalition for Epidemic Preparedness Innovations (CEPI) that is working

Latest news

More from news
Approximately 3 fully matching, plus 18 partially matching documents found.

Latest Intelligence

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    In March the CEPI called for new funding for the expansion of potential vaccine candidates, saying that $2bn is needed to support the development of a successful COVID-19 vaccine. ... stockpiled and ready for trials and emergency authorisation should an

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...